Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Pathways sufficient to induce epidermal carcinogenesis.

Ridky TW, Khavari PA.

Cell Cycle. 2004 May;3(5):621-4. Epub 2004 May 15. Review.

PMID:
15044848
2.

CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis.

Lazarov M, Kubo Y, Cai T, Dajee M, Tarutani M, Lin Q, Fang M, Tao S, Green CL, Khavari PA.

Nat Med. 2002 Oct;8(10):1105-14. Epub 2002 Sep 23.

PMID:
12357246
3.

Sonic hedgehog opposes epithelial cell cycle arrest.

Fan H, Khavari PA.

J Cell Biol. 1999 Oct 4;147(1):71-6.

4.

NF-kappaB and cell-cycle regulation: the cyclin connection.

Joyce D, Albanese C, Steer J, Fu M, Bouzahzah B, Pestell RG.

Cytokine Growth Factor Rev. 2001 Mar;12(1):73-90. Review.

PMID:
11312120
5.

CDK4 regulation by TNFR1 and JNK is required for NF-kappaB-mediated epidermal growth control.

Zhang JY, Tao S, Kimmel R, Khavari PA.

J Cell Biol. 2005 Feb 14;168(4):561-6. Epub 2005 Feb 7.

6.

NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.

Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ, Marinkovich MP, Tao S, Lin Q, Kubo Y, Khavari PA.

Nature. 2003 Feb 6;421(6923):639-43.

PMID:
12571598
7.

Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.

Fan S, Meng Q, Laterra JJ, Rosen EM.

Oncogene. 2007 Jul 19;26(33):4774-96. Epub 2007 Feb 12.

PMID:
17297451
8.

A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.

Casanova ML, Larcher F, Casanova B, Murillas R, Fernández-Aceñero MJ, Villanueva C, Martínez-Palacio J, Ullrich A, Conti CJ, Jorcano JL.

Cancer Res. 2002 Jun 15;62(12):3402-7.

9.

Vav transformation requires activation of multiple GTPases and regulation of gene expression.

Palmby TR, Abe K, Karnoub AE, Der CJ.

Mol Cancer Res. 2004 Dec;2(12):702-11.

11.

Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis.

Hsu TC, Young MR, Cmarik J, Colburn NH.

Free Radic Biol Med. 2000 May 1;28(9):1338-48. Review.

PMID:
10924853
12.

Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.

Kiguchi K, Bol D, Carbajal S, Beltrán L, Moats S, Chan K, Jorcano J, DiGiovanni J.

Oncogene. 2000 Aug 31;19(37):4243-54.

13.

Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.

Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD.

Oncogene. 2000 Sep 28;19(41):4685-94.

14.

Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).

Koong AC, Chen EY, Mivechi NF, Denko NC, Stambrook P, Giaccia AJ.

Cancer Res. 1994 Oct 15;54(20):5273-9.

15.

Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38-MAPK pathway.

Conejo R, de Alvaro C, Benito M, Cuadrado A, Lorenzo M.

Oncogene. 2002 May 23;21(23):3739-53.

17.

Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.

Mazières J, Tillement V, Allal C, Clanet C, Bobin L, Chen Z, Sebti SM, Favre G, Pradines A.

Exp Cell Res. 2005 Apr 1;304(2):354-64. Epub 2004 Dec 28.

PMID:
15748883
18.

Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog.

Fan H, Oro AE, Scott MP, Khavari PA.

Nat Med. 1997 Jul;3(7):788-92.

PMID:
9212109
19.

Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis.

Budunova IV, Perez P, Vaden VR, Spiegelman VS, Slaga TJ, Jorcano JL.

Oncogene. 1999 Dec 9;18(52):7423-31.

20.

Pathways involved in proliferating, senescent and immortalized keratinocyte cell death mediated by two different TRAIL preparations.

Qin JZ, Bacon PE, Chaturvedi V, Bonish B, Nickoloff BJ.

Exp Dermatol. 2002 Dec;11(6):573-83.

PMID:
12473065

Supplemental Content

Support Center